セッション情報

一般演題 (示説)

第53回・2015年・京都
一般演題 (示説)
示説52
Palliative:Chemotherapy and Supportive Care
開催回
第53回・2015年・京都

Randomized double-blind controlled trial of the pre-emptive steroid treatment on Hand-foot skin reaction with sorafenib (PRESSO)

演題番号 : P52-1

Matsumura Yumi:1、Hatano Etsuro:2、Yamamoto Yosuke:3、Katsushima Shinji:4、Ueno Makoto:5、Nagano Hiroaki:6、Sakaguchi Takanori:7、Kubo Shoji:8、Azechi Hidemasa:9、Takahashi Hideaki:10、Sugioka Atsushi:11、Ioka Tatsuya:12

1:Patient Safety Unit, Hospital, Kyoto University、2:Department of Surgery, Graduate School of Medicine, Kyoto University、3:Institute for Advancement of Clinical and Translational Science, Hospital, Kyoto University、4:National Hospital Organization Kyoto Medical Center、5:Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center、6:Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University、7:Second Department of Surgery, Faculty of Medicine, Hamamatsu University School of Medicine、8:Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Osaka City University、9:Kyoto Katsura Hospital、10:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East、11:Department of Surgery, School of Medicine, Fujita Health University、12:Department of Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases

Randomized double-blind controlled trial of the pre-emptive steroid treatment on Hand-foot skin reaction with sorafenib (PRESSO)

Withdrawn

演題番号 : P52-2

Withdrawn

Neutrophil-lymphcyte ratio predicts survival in patients with terminally Ill cancer

演題番号 : P52-3

Ahn Hee Kyung:1、Hwang In Cheol:2

1:Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center、2:Department of Family Medicine, Gachon University Gil Medical Center

Neutrophil-lymphcyte ratio predicts survival in patients with terminally Ill cancer

Delirium in terminal cancer inpatients at a tertiary hospice care unit

演題番号 : P52-4

Kim Hyojeong:1、Park Young Ju:1、Seol Young Mi:1、Choi Young Jin:1、Shin Ho-jin:1、Chung Joo-seop:1

1:Division of Hematooncology, Department of Internal Medicine, Pusan National University Hospital

Delirium in terminal cancer inpatients at a tertiary hospice care unit

Recombinant human soluble thrombomodulin in cancer-induced disseminated intravascular coagulation

演題番号 : P52-5

Koyama Takafumi:1、Hasegawa Yoriko:1、Hiramatsu Ayako:1、Fujisawa Takao:1、Hasegawa Akiko:1、Harada Yohei:1、Fujimoto Yumi:1、Hisamatsu Haruka:1、Saito Ayumi:1、Miura Daisuke:1、Oyama Yu:1

1:Medical Oncology, Kameda Medical Center

Recombinant human soluble thrombomodulin in cancer-induced disseminated intravascular coagulation

The comparison of E-PASS with mE-PASS to estimate the occurrence of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer

演題番号 : P52-6

Kitano Yuuki:1、Iwatsuki Masaaki:1、Kurashige Junji:1、Izumi Daisuke:1、Kosumi Keisuke:1、Tokunaga Ryuma:1、Harda Kazuto:1、Shigaki Hironobu:1、Karashima Ryuichi:1、Baba Yoshifumi:1、Sakamoto Yasuo:1、Miyamoto Yuji:1、Yoshida Naoya:1、Baba Hideo:1

1:Department of Gastroenterological Surgery, University Hospital, Kumamoto University

The comparison of E-PASS with mE-PASS to estimate the occurrence of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer

The potential impact of pegfilgrastim on adjuvant chemotherapy regimens and dosage, a single institution experience

演題番号 : P52-7

Kamada Yoshihiko:1、Tamatsu Youko:1、Arakaki Miwa:1、Yamashiro Kazuko:1、Tamaki Kentaro:1,2、Uehara Kano:1,2、Tamaki Nobumitsu:1,2

1:Department of Surgery, Nahanisi Clinic、2:Nahanishi Clinic Makabi

The potential impact of pegfilgrastim on adjuvant chemotherapy regimens and dosage, a single institution experience

Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer

演題番号 : P52-8

Aoyama Toru:1,2、Kawabe Taiichi:2、Fujikawa Hirohito:2、Hayashi Tsutomu:2、Yamada Takanobu:2、Sato Tsutomu:1,2、Ogata Takashi:1、Cho Haruhiko:1、Yamamoto Naoto:2、Oshima Takashi:2、Yukawa Norio:2、Morinaga Soichiro:1、Rino Yasushi:2、Masuda Munetaka:2、Yoshikawa Takaki:1,2

1:Gastrointestinal Surgery, Kanagawa Cancer Center、2:Department of Surgery, Yokohama City University

Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer

The impact of body fat distribution on neo-adjuvant chemotherapy for advanced breast cancer patients

演題番号 : P52-9

Iwase Toshiaki:1、Sangai Takafumi:1、Nakagawa Ayako:1、Masuda Takahito:1、Ishigami Emi:1、Hayama Shouko:1、Sakakibara Junta:1、Sakakibara Masahiro:1、Nagashima Takeshi:1、Miyazaki Masaru:1

1:Department of General Surgery, Graduate School, Chiba University

The impact of body fat distribution on neo-adjuvant chemotherapy for advanced breast cancer patients